Differences in ex-vivo Chemosensitivity to Anthracyclines in First Line Acute Myeloid Leukemia

机译：一线急性髓样白血病对蒽环类药物的离体化学敏感性差异

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundInduction schedules in acute myeloid leukemia (AML) are based on combinations of cytarabine and anthracyclines. The choice of the anthracycline employed has been widely studied in multiple clinical trials showing similar complete remission rates.

机译：背景急性髓细胞性白血病（AML）的诱导时间表基于阿糖胞苷和蒽环类药物的组合。蒽环类药物的选择已在多项临床试验中得到广泛研究，显示出完全缓解率相似。

著录项

期刊名称 Mediterranean Journal of Hematology and Infectious Diseases
作者
Juan Eduardo Megías-Vericat; David Martínez-Cuadrón; Joaquín Martínez López; Juan Miguel Bergua; Mar Tormo; Josefina Serrano; Ataulfo González; Jaime Pérez de Oteyza; Susana Vives; Belén Vidriales; Pilar Herrera; Juan Antonio Vera; Aurelio López Martínez; Adolfo de la Fuente; Ma Lourdes Amador; José-Ángel Hernández-Rivas; Ma Ángeles Fernández; Carlos Javier Cerveró; Daniel Morillo; Pilar Hernández Campo; Julián Gorrochategui; Daniel Primo; José Luis Rojas; Margarita Guenova; Joan Ballesteros; Miguel Sanz; Pau Montesinos;
展开▼
作者单位

展开▼
年(卷),期 2019(11),1
年度 2019
页码 e2019016
总页数 11
原文格式 PDF
正文语种
中图分类血液学检验;
关键词
Anthracycline ex-vivo test Idarubicin Daunorubicin Mitoxantrone Acute myeloid leukemia Personalized medicine;

机译：蒽环类药物;离体试验;依达比星;柔红霉素;米托蒽醌;急性髓细胞性白血病;个性化药物;
入库时间 2022-08-17 11:42:39

相似文献

外文文献
中文文献
专利

1. DIFFERENCES IN EX-VIVO CHEMOSENSITIVITY TO ANTHRACYCLINES IN FIRST LINE ACUTE MYELOID LEUKEMIA [J] . Juan Eduardo Megias-Vericat, David Martínez-Cuadrón, Joaquin Martínez López, Mediterranean Journal of Hematology and Infectious Diseases . 2019,第1期

机译：第一线急性髓性白血病的体外对蒽环类药物的化学敏感性差异
2. Age- specific differences in oncogenic pathway dysregulation and anthracycline sensitivity in patients with acute myeloid leukemia (Journal of Clinical Oncology (2009) 27 (5580-5586)) [J] . Journal of Clinical Oncology . 2012,第5期

机译：急性髓细胞性白血病患者的致癌途径失调和蒽环类药物敏感性的年龄差异（临床肿瘤学杂志（2009）27（5580-5586））
3. Age-specific differences in oncogenic pathway dysregulation and anthracycline sensitivity in patients with acute myeloid leukemia. [J] . Rao AV, Valk PJ, Metzeler KH, Journal of Clinical Oncology . 2009,第33期

机译：急性髓样白血病患者的致癌途径失调和蒽环类药物敏感性的年龄差异。
4. K-Means Clustering on 3^rd order polynomial based normalization of Acute Myeloid Leukemia (AML) and Acute Lymphocyte Leukemia (ALL) [C] . Mehdi A.M., Sehgal M.S., Zayegh A., Electrical Engineering, 2009. ICEE '09 . 2009

机译：基于3 ^{rd 多项式的K均值聚类基于急性髓细胞白血病（AML）和急性淋巴细胞白血病（ALL）的归一化}
5. Loss of Egr1 plays a role in murine leukemogenesis and may play a role in the development of acute myeloid leukemia and therapy-related acute myeloid leukemia. [D] . Joslin, John M. 2006

机译：Egr1的丢失在小鼠白血病的发生中起作用，并且可能在急性髓细胞性白血病和与治疗有关的急性髓细胞性白血病的发展中起作用。
6. Pharmacometabolomics identifies dodecanamide and leukotriene B4 dimethylamide as a predictor of chemosensitivity for patients with acute myeloid leukemia treated with cytarabine and anthracycline [O] . Guangguo Tan, Bingbing Zhao, Yanqing Li, 2017

机译：药物代谢组学确定十二烷酰胺和白三烯B4二甲基酰胺可作为阿糖胞苷和蒽环类药物治疗的急性髓细胞性白血病患者化学敏感性的预测指标
7. Regulation of c-fos gene transcription and myeloid cell differentiation by acute myeloid leukemia 1 and acute myeloid leukemia-MTG8, a chimeric leukemogenic derivative of acute myeloid leukemia 1 [O] . Hwang Eun Sook, Hong Jeong-Ho, Bae Suk Chul, 1999

机译：急性髓性白血病1和急性髓性白血病MTG8（急性髓性白血病1的嵌合致白血病衍生物）对c-fos基因转录和髓细胞分化的调节

Differences in ex-vivo Chemosensitivity to Anthracyclines in First Line Acute Myeloid Leukemia

摘要

著录项

相似文献

相关主题

期刊订阅